Activation of the AT1R/HIF-1 α /ACE Axis Mediates Angiotensin II-Induced VEGF Synthesis in Mesenchymal Stem Cells

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Liu, Chao ^a   Zhang, Jing Wen ^a   Hu, Liang ^a   Song, Yi Chen ^a   Zhou, Lu ^a   Fan, Yue ^a   Zhu, Hong Yi ^a   Wang, Yu ^a   Li, Qing Ping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR 1; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MESENCHYMAL STROMAL CELLS; PEPTIDYL-DIPEPTIDASE A; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84911032637     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/627380     Document Type: Article

References (33)

1. Strawn W. B., Richmond R. S., Tallant E. A., Gallagher P. E., Ferrario C. M., Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. British Journal of Haematology 2004 126 1 120 126 10.1111/j.1365-2141.2004.04998.x 2-s2.0-3042748331
2. Schächinger V., Assmus B., Britten M. B., Honold J., Lehmann R., Teupe C., Abolmaali N. D., Vogl T. J., Hofmann W.-K., Martin H., Dimmeler S., Zeiher A. M., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. Journal of the American College of Cardiology 2004 44 8 1690 1699 10.1016/j.jacc.2004.08.014 2-s2.0-5644236574
3. Nagaya N., Kangawa K., Itoh T., Iwase T., Murakami S., Miyahara Y., Fujii T., Uematsu M., Ohgushi H., Yamagishi M., Tokudome T., Mori H., Miyatake K., Kitamura S., Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005 112 8 1128 1135 10.1161/CIRCULATIONAHA.104.500447 2-s2.0-24044535092
4. Uemura R., Xu M., Ahmad N., Ashraf M., Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circulation Research 2006 98 11 1414 1421 10.1161/01.RES.0000225952.61196.39 2-s2.0-33745356932
5. Gnecchi M., He H., Noiseux N., Liang O. D., Zhang L., Morello F., Mu H., Melo L. G., Pratt R. E., Ingwall J. S., Dzau V. J., Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. The FASEB Journal 2006 20 6 661 669 10.1096/fj.05-5211com 2-s2.0-33646252939
6. Shi R.-Z., Wang J.-C., Huang S.-H., Wang X.-J., Li Q.-P., Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells. Experimental Cell Research 2009 315 10 15 10.1016/j.yexcr.2008.09.024
7. Yasumatsu R., Nakashima T., Masuda M., Ito A., Kuratomi Y., Nakagawa T., Komune S., Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. Journal of Cancer Research and Clinical Oncology 2004 130 10 567 573 10.1007/s00432-004-0582-7 2-s2.0-5644304562
8. Volpert O. V., Ward W. F., Lingen M. W., Chesler L., Solt D. B., Johnson M. D., Molteni A., Polverini P. J., Bouck N. P., Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. Journal of Clinical Investigation 1996 98 3 671 679 10.1172/JCI118838 2-s2.0-0029916051
9. Yoshiji H., Kuriyama S., Kawata M., Yoshii J., Ikenaka Y., Noguchi R., Nakatani T., Tsujinoue H., Fukui H., The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clinical Cancer Research 2001 7 4 1073 1078 2-s2.0-0034907881
10. Hii S.-I., Nicol D. L., Gotley D. C., Thompson L. C., Green M. K., Jonsson J. R., Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma. British Journal of Cancer 1998 77 6 880 883 10.1038/bjc.1998.145 2-s2.0-0031937612
11. Arafat H. A., Gong Q., Chipitsyna G., Rizvi A., Saa C. T., Yeo C. J., Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. Journal of the American College of Surgeons 2007 204 5 996 1005 10.1016/j.jamcollsurg.2007.01.067 2-s2.0-34247511935
12. Yoshiji H., Kuriyama S., Fukui H., Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma: possible role of vascular endothelial growth factor. Tumor Biology 2002 23 6 348 356 10.1159/000069792 2-s2.0-0037963091
13. Pugh C. W., Ratcliffe P. J., Regulation of angiogenesis by hypoxia: role of the HIF system. Nature Medicine 2003 9 6 677 684 10.1038/nm0603-677 2-s2.0-0038037735
14. Fukuda R., Hirota K., Fan F., Jung Y. D., Ellis L. M., Semenza G. L., Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. The Journal of Biological Chemistry 2002 277 41 38205 38211 10.1074/jbc.M203781200 2-s2.0-0037064010
15. Fukuda R., Kelly B., Semenza G. L., Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Research 2003 63 9 2330 2334 2-s2.0-0038375038
16. Erwin G. S., Crisostomo P. R., Wang Y., Wang M., Markel T. A., Guzman M., Sando I. C., Sharma R., Meldrum D. R., Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia. Journal of Surgical Research 2009 152 2 319 324 10.1016/j.jss.2008.02.006 2-s2.0-61849084197
17. Richard D. E., Berra E., Pouyssegur J., Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1 α in vascular smooth muscle cells. The Journal of Biological Chemistry 2000 275 35 26765 26771 10.1074/jbc.M003325200 2-s2.0-0034282388
18. Kazi A. A., Koos R. D., Estrogen-induced activation of hypoxia-inducible factor-1 α vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology 2007 148 5 2363 2374 10.1210/en.2006-1394 2-s2.0-34249799626
19. Zhang R., Wu Y., Zhao M., Liu C., Zhou L., Shen S., Liao S., Yang K., Li Q., Wan H., Role of HIF-1 α in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. The American Journal of Physiology-Lung Cellular and Molecular Physiology 2009 297 4 L631 L640 10.1152/ajplung.90415.2008 2-s2.0-70349774464
20. Hahn J. Y., Cho H. J., Kang H. J., Kim T. S., Kim M. H., Chung J. H., Bae J. W., Oh B. H., Park Y. B., Kim H. S., Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. Journal of the American College of Cardiology 2008 51 9 933 943 10.1016/j.jacc.2007.11.040 2-s2.0-39549105786
21. Schling P., Schäfer T., Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity. The Journal of Biological Chemistry 2002 277 50 48066 48075 10.1074/jbc.M204058200 2-s2.0-0037073743
22. Tsai M.-S., Hwang S.-M., Chen K.-D., Lee Y.-S., Hsu L.-W., Chang Y.-J., Wang C.-N., Peng H.-H., Chang Y.-L., Chao A.-S., Chang S.-D., Lee K.-D., Wang T.-H., Wang H.-S., Soong Y.-K., Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 2007 25 10 2511 2523 10.1634/stemcells.2007-0023 2-s2.0-35348861286
23. Katsuda T., Tsuchiya R., Kosaka N., Yoshioka Y., Takagaki K., Oki K., Takeshita F., Sakai Y., Kuroda M., Ochiya T., Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Scientific Reports 2013 3, article no. 1197 10.1038/srep01197 2-s2.0-84873688339
24. Schunkert H., Ingelfinger J. R., Hirsch A. T., Pinto Y., Remme W. J., Jacob H., Dzau V. J., Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circulation Research 1993 72 2 312 318 10.1161/01.RES.72.2.312 2-s2.0-0027444274
25. Sadjadi J., Kramer G. L., Yu C.-H., Welborn M. B. III, Modrall J. G., Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism. Journal of Surgical Research 2005 129 2 272 277 10.1016/j.jss.2005.04.044 2-s2.0-29144496996
26. Zou L.-X., Imig J. D., von Thun A. M., Hymel A., Ono H., Navar L. G., Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension 1996 28 4 669 677 10.1161/01.HYP.28.4.669 2-s2.0-0029797409
27. Pagé E. L., Robitaille G. A., Pouysségur J., Richard D. E., Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. The Journal of Biological Chemistry 2002 277 48403 48409 10.1074/jbc.M209114200
28. Sánchez-López E., López A. F., Esteban V., Yagüe S., Egido J., Ruiz-Ortega M., Álvarez-Arroyo M. V., Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1 α induction and redox mechanisms in the kidney. Antioxidants and Redox Signaling 2005 7 9-10 1275 1284 10.1089/ars.2005.7.1275 2-s2.0-24144469144
29. Krick S., Hänze J., Eul B., Savai R., Seay U., Grimminger F., Lohmeyer J., Klepetko W., Seeger W., Rose F., Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1 α and an autocrine angiotensin system. The FASEB Journal 2005 19 7 857 859 10.1096/fj.04-2890fje 2-s2.0-20944432353
30. Zhang J., Hu L., Liu C., Wang L., Li Q., Involvement of signal transducer and activator of transcription 3 in angiotensin II-upregulated vascular endothelial growth factor production in mesenchymal stem cells. Acta Universitatis Medicinalis Nanjing (Natural Science) 2012 32 891 895
31. Wang M., Tan J., Coffey A., Fehrenbacher J., Weil B. R., Meldrum D. R., Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1 α mediates estrogen receptor- α -induced mesenchymal stem cell vascular endothelial growth factor production. Journal of Thoracic and Cardiovascular Surgery 2009 138 1 163.e1 171.e1 10.1016/j.jtcvs.2009.03.010 2-s2.0-67649390844
32. Jung J. E., Lee H. G., Cho I. H., Chung D. H., Yoon S.-H., Yang Y. M., Lee J. W., Choi S., Park J.-W., Ye S.-K., Chung M.-H., STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. The FASEB Journal 2005 19 10 1296 1298 10.1096/fj.04-3099fje 2-s2.0-23444449093
33. Xu Q., Briggs J., Park S., Niu G., Kortylewski M., Zhang S., Gritsko T., Turkson J., Kay H., Semenza G. L., Cheng J. Q., Jove R., Yu H., Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 2005 24 36 5552 5560 10.1038/sj.onc.1208719 2-s2.0-24644457736